TrialIntensive care medicine2015

Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.

Serge Masson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.